Related Experiment Video
Updated: May 31, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
WWC proteins-mediated compensatory mechanism restricts schwannomatosis driven by NF2 loss of function
Xueying Wang1, Rui Zhu1, Pengcheng Yu1
1Institute of Pediatrics, Children's Hospital of Fudan University, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, State Key Laboratory of Genetic Engineering, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Abstract:
NF2-related schwannomatosis, previously known as neurofibromatosis type 2, is a genetic disorder characterized by nerve tumors due to NF2 gene mutations. Mice with Nf2 deletion develop schwannomas slowly with low penetrance, hence inconvenient for preclinical studies. Here, we show that NF2, by recruiting E3 ubiquitin ligases β-TrCP1/2, promotes WWC1-3 ubiquitination and degradation. In NF2 mutated cells, WWC1-3 accumulation is a compensatory mechanism to prevent YAP/TAZ hyperactivation and rapid tumorigenesis. Accordingly, we generate a synthetic mouse model with complete penetrance and short latency by concurrently deleting Nf2 and Wwc1/2 in Schwann cells. This model closely resembles NF2-related schwannomatosis in patients, as confirmed by histological and single-cell transcriptome analysis. Moreover, a cell line from mouse schwannomas and a syngeneic tumor model in immune-competent mice are established. Furthermore, a screen using established models has identified candidate drugs that effectively suppress schwannoma progression. Hence, this work has developed rapid and transplantable models that will facilitate both basic and translational research on NF2-related schwannomatosis.
Insights
Researchers developed a new mouse model for NF2-related schwannomatosis by deleting Nf2 and Wwc1/2 genes. This model enables faster preclinical studies and drug screening for nerve tumors.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- NF2-related schwannomatosis (NF2) is a genetic disorder caused by NF2 gene mutations, leading to nerve tumors.
- Existing mouse models for NF2 exhibit slow tumor development and low penetrance, hindering preclinical research.
- NF2 protein normally recruits E3 ubiquitin ligases to degrade WWC1-3, preventing YAP/TAZ hyperactivation.
Purpose of the Study:
- To develop a more effective preclinical model for NF2-related schwannomatosis.
- To investigate the role of WWC1-3 accumulation in NF2-mutated cells.
- To identify potential therapeutic drugs for NF2-related schwannomatosis.
Main Methods:
- Generated a novel mouse model by concurrently deleting Nf2 and Wwc1/2 genes in Schwann cells.
- Utilized histological and single-cell transcriptome analysis for model validation.
- Established a cell line and syngeneic tumor model for drug screening.
Main Results:
- The new mouse model displays complete penetrance and short latency, closely mimicking human NF2-related schwannomatosis.
- WWC1-3 accumulation was observed as a compensatory mechanism in NF2-mutated cells.
- Identified candidate drugs that effectively inhibit schwannoma progression in the developed models.
Conclusions:
- Developed rapid, transplantable mouse models for NF2-related schwannomatosis research.
- These models will accelerate basic and translational studies for NF2.
- Identified potential therapeutic strategies for treating nerve tumors in NF2.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Neurogenesis and Regeneration of Nervous Tissue
Abnormal Proliferation
Pleiotropy